Standard Biotools | FLDM - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 10.2M 66.1M 2026-03
Danaher USD 1.34B 158M 2026-03
Illumina USD 239M 17M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Nikon Corporation JPY -8.82B 89.99B 2026-03
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Revvity USD 82.77M 63.06M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sony JPY 229.31B 280.79B 2026-03
Standard Biotools USD -9.42M 12.51M 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 148M 122.52M 2026-03